Calendar

Monday Jan 5,2026
Estimate Eps
Actual Eps
Eps Surprise
Estimate Revenue
Actual Revenue
Revenue Surprise
Period
logo
BBNX
Beta Bionics
-0.37 USD
--
--
28.90M USD
--
--
Q4 2025
Backtest
The backtest results indicate that BBNX shows a strong positive price reaction to earnings beats, with a 50% win rate over 3 days improving to 100% over 10 and 30 days, and a notable 30-day return of 30.83%. This suggests increasing investor confidence and momentum following positive earnings surprises. In contrast, the Health Care Equipment & Supplies Industry exhibits minimal price movement after earnings beats, indicating limited sector-wide impact. Investors may find it beneficial to hold BBNX shares for at least a month post-earnings beat to maximize returns, while relying less on sector trends.